Bidirectional Tachycardia in a Case of Recurrent Paroxysmal Tachycardia with Ventricular Fibrillation

Research Articles| October 22 2008 Bidirectional Tachycardia in a Case of Recurrent Paroxysmal Tachycardia with Ventricular Fibrillation Subject Area: Cardiovascular System T. Dyk; T. Dyk 3rd Department of Internal Medicine of Gdańsk Medical Academy, Gdańsk Search for other works by this author on: This Site PubMed Google Scholar C. Janukowicz C. Janukowicz 3rd Department of Internal Medicine of Gdańsk Medical Academy, Gdańsk Search for other works by this author on: This Site PubMed Google Scholar Cardiologia (1968) 52 (3): 132–137. https://doi.org/10.1159/000166110 Article history Published Online: October 22 2008 Content Tools Views Icon Views Article contents Figures Bidirectional Tachycardia in a Case of Recurrent Paroxysmal Tachycardia with Ventricular Fibrillation. Cardiologia 1 March 1968; 52 (3): 132–137. https://doi.org/10.1159/000166110 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsCardiologia Search Advanced Search Article PDF first page preview Close Modal Keywords: Bidirectional ventricular tachycardia, Supraventricular tachycardia, Ventricular fibrillation, Paroxysmal tachycardia This content is only available via PDF. 1968Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. You do not currently have access to this content.